companydata.dkcompanydata.dk

CHR. OLESEN PHARMACEUTICALS A/S: Financial statements 2020

CVR: 32090168

Source: annual report 2020, Danish Business Authority

01/10/2019 – 30/09/2020

CHR. OLESEN PHARMACEUTICALS A/S (CVR 32090168) has filed annual accounts for 2020. In 2020, the company reported a gross profit of EUR 1,026,370 and a net result of EUR 454,764 compared with EUR 474,910 the year before. That is a decrease of 4% compared with the year before. Equity in the 2020 report amounted to EUR 599,172. The solvency ratio was 6.4%. The company had 1 employee in the financial year.

Gross Profit
EUR 1,026,370
Profit/Loss
EUR 454,764
Equity
EUR 599,172
Total Assets
EUR 9,413,553
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1M EUR455K EUR599K EUR1
2019-1.1M EUR475K EUR444K EUR1
2018-468K EUR96K EUR-31K EUR1
2017-529K EUR128K EUR-126K EUR1
2016-395K EUR21K EUR-254K EUR1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is CHR. OLESEN PHARMACEUTICALS A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

CHR. OLESEN PHARMACEUTICALS A/S: The 2019 annual report is outFeb 27, 2020

CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2019. Gross profit came to DKK 1,069,171, and the net result was DKK 474,910.

About CHR. OLESEN PHARMACEUTICALS A/S

CHR. OLESEN PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christian Dam Olesen, Mads Christian Olesen and Phillip Christian Dam Quitzau Olesen. The board consists of Tobias Facklam (chair), Christian Dam Olesen and Fabian von Volkmann. The company is owned by CHR. OLESEN A/S and SVVF UG & Co. KG. The company has 2 employees (2026). In 2025, the company reported a gross profit of EUR 1,210,782 and a net result of EUR 237,447 compared with EUR 70,556 the year before. Equity in the 2025 report amounted to EUR 1,744,707.

Source: annual report 2025, Danish Business Authority